...
机译:基于辅助蒽环类的VS度量化化疗与转移脾血管瘤的狗没有医疗:对意大利肿瘤学会的多制度回顾性研究
Centro Oncologico VeterinarioBologna Italy;
Department of Veterinary Medical SciencesUniversity of BolognaBologna Italy;
Department of Small Animal Clinical ScienceInstitute of Veterinary Science University of LiverpoolNeston UK;
North Downs Specialist ReferralsBletchingley UK;
Centro Veterinario TorineseTurin Italy;
Clinica Veterinaria TibaldiMilan Italy;
Department of Veterinary MedicineUniversity of MilanMilan Italy;
Centro Medico Veterinario BMVetBari Italy;
Department of Veterinary Medical SciencesUniversity of BolognaBologna Italy;
Department of Veterinary Medical SciencesUniversity of BolognaBologna Italy;
Ospedale Veterinario Città di PaviaPavia Italy;
Department of Veterinary Medical SciencesUniversity of BolognaBologna Italy;
dog; hemangiosarcoma; maximum tolerated chemotherapy; metastasis; metronomic chemotherapy; prognosis;
机译:基于辅助蒽环类的VS度量化化疗与转移脾血管瘤的狗没有医疗:对意大利肿瘤学会的多制度回顾性研究
机译:Xelox Plus Bevacizumab与Folfiri加上贝伐单抗治疗一线化疗转移癌症癌症:一种回顾性研究医学肿瘤学会
机译:手术后围手术期并发症和结果治疗犬胃癌:兽医社会40例外科肿瘤学研究(2004-2018)
机译:单独对截肢治疗的犬阑尾细胞肉瘤:28只狗的外科肿瘤学研究兽医学会
机译:高剂量Neoadjuvant ChemorAderapy治疗与化疗单独进行然后在潜在的可重置阶段IIIA-N2 NSCLC中进行手术。肿瘤群研究肺癌研究的多机构回顾性研究(西班牙辐射肿瘤学会)
机译:Xelox Plus Bevacizumab与Folfiri加上贝伐单抗治疗一线化疗转移癌症癌症:一种回顾性研究医学肿瘤学会